Dr. Joseph Peter Mirante, MD

Dr. Mirante practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Mirante's NPI, 1245214022, was assigned on December 5, 2005. Dr. Mirante graduated from Icahn School Of Medicine At Mount Sinai in 1987. Dr. Mirante holds Florida license ME67681.

Dr. Mirante's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Mirante's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. Mirante is also affiliated with AdventHealth Daytona Beach. The medical group on file is South Florida ENT Associates. Dmand AI also links Dr. Mirante to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirante practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Mirante's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Mirante is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Mirante's licenses on file in 3 states: Florida, California and New York.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear and tinnitus among the conditions Dr. Mirante treats.

CMS data shows 4,261 Medicare services from Dr. Mirante across 12 procedure codes in 2024, for 1,208 Medicare patients. Medicare paid $333,375 for them. Every service was in an office.

CMS counts 1,208 Medicare patients who saw Dr. Mirante in 2024. The largest group is 75 to 84, with 567 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mirante's median patient age at 75, with 59% women.

In 2024, Dr. Mirante wrote 2,302 Medicare Part D claims for 807 patients. 98% of them were for generic drugs. CMS names the drug for 2,190 of them, across 21 drugs with 11 or more claims each, at $45,604 in total drug cost. In 2023, CMS named 1,886 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mirante for performance year 2024, reported individually. Dr. Mirante accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 132 papers to Dr. Mirante in 2019. 2019 was the busiest year, with 6. The most frequent topics are Endoscopy, Tomography, X-Ray Computed and Turbinates. Dr. Mirante has published most often in Ear Nose Throat J. Dr. Mirante's most frequent co-authors are Dewey A. Christmas, MD, Ken Yanagisawa, MD and Jonathan E. Aviv, MD.

CMS Open Payments shows 3 general payments to Dr. Mirante from 3 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Neurent Medical Limited paid the most, $152.

Dmand AI lists 3 awards for Dr. Mirante, most recently AAO-HNS Fellow in 2013.

Dr. Mirante graduated from Icahn School Of Medicine At Mount Sinai in 1987. Dr. Mirante is a member of NHS and ACS.

Dr. Mirante is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.